Danaher (NYSE:DHR) Stock Price Expected to Rise, Deutsche Bank Aktiengesellschaft Analyst Says

Danaher (NYSE:DHR) had its target price raised by investment analysts at Deutsche Bank Aktiengesellschaft from $235.00 to $250.00 in a research note issued on Wednesday,MarketScreener reports. The brokerage presently has a “buy” rating on the conglomerate’s stock. Deutsche Bank Aktiengesellschaft’s target price indicates a potential upside of 12.30% from the stock’s current price.

A number of other analysts have also recently commented on DHR. Bank of America reduced their target price on shares of Danaher from $230.00 to $220.00 and set a “buy” rating for the company in a report on Monday, September 22nd. Wells Fargo & Company dropped their price target on shares of Danaher from $210.00 to $205.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 23rd. Scotiabank upgraded shares of Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price target for the company in a research report on Friday, July 11th. Evercore ISI upped their price target on shares of Danaher from $226.00 to $245.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 7th. Finally, Royal Bank Of Canada set a $241.00 price target on shares of Danaher in a research report on Tuesday, September 2nd. Eighteen analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $243.39.

Danaher Stock Up 2.1%

Shares of DHR stock opened at $222.62 on Wednesday. Danaher has a 12 month low of $171.00 and a 12 month high of $258.23. The stock has a market cap of $157.25 billion, a P/E ratio of 45.90, a P/E/G ratio of 3.31 and a beta of 0.77. The company has a current ratio of 1.52, a quick ratio of 1.22 and a debt-to-equity ratio of 0.33. The company has a 50 day simple moving average of $202.49 and a two-hundred day simple moving average of $198.02.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, October 21st. The conglomerate reported $1.89 EPS for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The business had revenue of $6.05 billion during the quarter, compared to analysts’ expectations of $6 billion. During the same period in the prior year, the company earned $1.71 earnings per share. The firm’s revenue was up 4.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, research analysts expect that Danaher will post 7.63 earnings per share for the current year.

Insider Buying and Selling at Danaher

In related news, Director Teri List sold 2,778 shares of the company’s stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the transaction, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 11.10% of the company’s stock.

Hedge Funds Weigh In On Danaher

Several institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. lifted its position in Danaher by 1.3% during the second quarter. Vanguard Group Inc. now owns 60,769,587 shares of the conglomerate’s stock valued at $12,004,424,000 after purchasing an additional 788,499 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its position in Danaher by 3.2% during the first quarter. Price T Rowe Associates Inc. MD now owns 19,592,211 shares of the conglomerate’s stock valued at $4,016,404,000 after purchasing an additional 612,154 shares during the last quarter. Geode Capital Management LLC lifted its position in Danaher by 0.6% during the second quarter. Geode Capital Management LLC now owns 13,726,194 shares of the conglomerate’s stock valued at $2,697,800,000 after purchasing an additional 81,670 shares during the last quarter. Norges Bank bought a new position in Danaher during the second quarter valued at $1,979,503,000. Finally, Bank of New York Mellon Corp lifted its position in Danaher by 2.3% during the first quarter. Bank of New York Mellon Corp now owns 8,783,485 shares of the conglomerate’s stock valued at $1,800,614,000 after purchasing an additional 194,466 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.